Inhaled drug delivery: a randomized study in intubated patients with healthy lungs

Background The administration technique for inhaled drug delivery during invasive ventilation remains debated. This study aimed to compare in vivo and in vitro the deposition of a radiolabeled aerosol generated through four configurations during invasive ventilation, including setups optimizing drug...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of Intensive Care 2023-12, Vol.13 (1), p.125-125, Article 125
Hauptverfasser: Dugernier, Jonathan, Le Pennec, Déborah, Maerckx, Guillaume, Allimonnier, Laurine, Hesse, Michel, Castanares-Zapatero, Diego, Depoortere, Virginie, Vecellio, Laurent, Reychler, Gregory, Michotte, Jean-Bernard, Goffette, Pierre, Docquier, Marie-Agnes, Raftopoulos, Christian, Jamar, François, Laterre, Pierre-François, Ehrmann, Stephan, Wittebole, Xavier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The administration technique for inhaled drug delivery during invasive ventilation remains debated. This study aimed to compare in vivo and in vitro the deposition of a radiolabeled aerosol generated through four configurations during invasive ventilation, including setups optimizing drug delivery. Methods Thirty-one intubated postoperative neurosurgery patients with healthy lungs were randomly assigned to four configurations of aerosol delivery using a vibrating-mesh nebulizer and specific ventilator settings: (1) a specific circuit for aerosol therapy (SCAT) with the nebulizer placed at 30 cm of the wye, (2) a heated-humidified circuit switched off 30 min before the nebulization or (3) left on with the nebulizer at the inlet of the heated-humidifier, (4) a conventional circuit with the nebulizer placed between the heat and moisture exchanger filter and the endotracheal tube. Aerosol deposition was analyzed using planar scintigraphy. Results A two to three times greater lung delivery was measured in the SCAT group, reaching 19.7% (14.0–24.5) of the nominal dose in comparison to the three other groups ( p  
ISSN:2110-5820
2110-5820
DOI:10.1186/s13613-023-01220-y